A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): Inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2

Nature Medicine

Volumn 9, Issue 4, 2003, Pages 407-415

  Qi, Jian Hua ^a   Ebrahem, Quteba ^a   Moore, Nina ^a   Murphy, Gillian ^b   Claesson Welsh, Lena ^c   Bond, Mark ^d   Baker, Andrew ^e   Anand Apte, Bela ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UPPSALA UNIVERSITY   (Sweden)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 3; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BINDING KINETICS; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SWINE;

CELL DIVISION; CELL LINE; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; NEOVASCULARIZATION, PATHOLOGIC; NEUROPILINS; PHOSPHORYLATION; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RECOMBINANT PROTEINS; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TISSUE INHIBITOR OF METALLOPROTEINASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA; SUS SCROFA;

EID: 0037393850     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm846     Document Type: Article

References (47)

1. Fong, G.H., Rossant, J., Gertsenstein, M. & Breitman, M.L. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376, 66-70 (1995).
2. Shalaby, F. et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-66 (1995).
3. Shalaby, F. et al. A requirement for Flkl in primitive and definitive hematopoiesis and vasculogenesis. Cell 89, 981-990 (1997).
4. Terman, B.I. et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun. 187, 1579-1586 (1992).
5. Millauer, B. et al. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72, 835-846 (1993).
6. Quinn, T.P., Peters, K.G., De Vries, C., Ferrara, N. & Williams, L.T. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc. Natl. Acad. Sci. USA 90, 7533-7537 (1993).
7. Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M. & Heldin, C.H. Different signal transduction properties of KDR and Fltl, two receptors for vascular endothelial growth factor. J. Biol. Chem. 269, 26988-26995 (1994).
8. de Vries, C. et al. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255, 989-991 (1992).
9. Seetharam, L. et al. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene 10, 135-147 (1995).
10. Pepper, M.S., Montesano, R., Mandriota, S.J., Orci, L. & Vassalli, J.-D. Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. Enzyme Protein 49, 138-162 (1996).
11. Hiraoka, N., Allen, E., Apel, I.J., Gyetko, M.R. & Weiss, S.J. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 95, 365-377 (1998).
12. Stetler-Stevenson, W.G. The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis. Surg. Oncol. Clin. N. Am. 10, 383-392 (2001).
13. Werb, Z., Vu, T.H., Rinkenberger, J.L. & Coussens, L.M. Matrix-degrading proteases and angiogenesis during development and tumor formation. APMIS 107, 11-18 (1999).
14. Itoh, T. et al. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 58, 1048-1051 (1998).
15. Anand-Apte, B. et al. A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth. Biochem. Cell Biol. 74, 853-862 (1996).
16. Anand-Apte, B. et al. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest. Ophthalmol. Vis. Sci. 38, 817-823 (1997).
17. Apte, S.S., Mattei, M.-G. & Olsen, B.R. Cloning of the cDNA encoding human tissue inhibitor of metalloproteinase-3 (TIMP-3) and mapping of the TIMP-3 gene to chromosome 22. Genomics 19, 86-90 (1994).
18. Langton, K.P. et al. A novel tissue inhibitor of metalloproteinases-3 mutation reveals a common molecular phenotype in Sorsby's fundus dystrophy. J. Biol. Chem. 275, 27027-27031 (2000).
19. Tabata, Y., Isashiki, Y., Kamimura, K., Nakao, K. & Ohba, N. A novel splice site mutation in the tissue inhibitor of the metalloproteinases-3 gene in Sorsby's fundus dystrophy with unusual clinical features. Hum. Genet. 103, 179-182 (1998).
20. Weber, B.H., Vogt, G., Pruett, R.C., Stohr, H. & Felbor, U. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat. Genet. 8, 352-356 (1994).
21. Nguyen, M., Shing, Y. & Folkman, J. Quantitation of angiogenesis and anti-angiogenesis in the chick embryo chorioallantoic membrane. Microvasc. Res. 47, 31-40 (1994).
22. Spurbeck, W.W., Ng, C.Y., Strom, T.S., Vanin, E.F. & Davidoff, A.M. Enforced expression of tissue inhibitor of matrix metalloproteinase-3 affects functional capillary morphogenesis and inhibits tumor growth in a murine tumor model. Blood 100, 3361-3368 (2002).
23. Bond, M. et al. Localization of the death domain of tissue inhibitor of metalloproteinase-3 to the N terminus. Metalloproteinase inhibition is associated with proapoptotic activity. J. Biol. Chem. 275, 41358-41363 (2000).
24. Ahonen, M., Baker, A.H. & Kahari, V.M. Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinase-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res. 58, 2310-2315 (1998).
25. Baker, A.H., Zaltsman, A.B., George, S.J. & Newby, A.C. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. J. Clin. Invest. 101, 1478-1487 (1998).
26. Baker, A.H., George, S.J., Zaltsman, A.B., Murphy, G. & Newby, A.C. Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3. Br. J. Cancer 79, 1347-1355 (1999).
27. Langton, K.P., Barker, M.D. & McKie, N. Localization of the functional domains of human tissue inhibitor of metalloproteinases-3 and the effects of a Sorsby's fundus dystrophy mutation. J. Biol. Chem. 273, 16778-16781 (1998).
28. Bergers, G. et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2, 737-744 (2000).
29. Coussens, L.M., Tinkle, C.L., Hanahan, D. & Werb, Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103, 481-490 (2000).
30. Hoegy, S.E., Oh, H.R., Corcoran, M.L. & Stetler-Stevenson, W.G. Tissue inhibitor of metalloproteinases-2 (TIMP-2) suppresses TKR-growth factor signaling independent of metalloproteinases inhibition. J. Biol. Chem. 276, 3203-3214 (2001).
31. Fariss, R.N., Apte, S.S., Luthert, P.J., Bird, A.C. & Milam, A.H. Accumulation of tissue inhibitor of metalloproteinase-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa. Br. J. Ophthalmol. 82, 1329-1334 (1998).
32. Kamei, M. & Hollyfield, J. TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 40, 2367-2375 (1999).
33. Della, N.G., Campochiaro, P.A. & Zack, D.J. Localization of TIMP-3 mRNA expression to the retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 37, 1921-1924 (1996).
34. Ruiz, A., Peterson, B. & Bok, D. Localization and quantification of TIMP-3 mRNA in the human retina. Invest. Ophthalmol. Vis. Sci. 37, S1143 (1996).
35. Blaauwgeers, H.G. et al. Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. Am. J. Pathol. 155, 421-428 (1999).
36. Bian, J. et al. Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3. Carcinogenesis 17, 1805-1811 (1996).
37. Ahonen, M. et al. Antitumor activity and bystander effect of adenovirally delivered tissue inhibitor of metalloproteinases-3. Mol. Ther. 5, 705-715 (2002).
38. Sun, Y. et al. Molecular cloning of mouse tissue inhibitor of metalloproteinases-3 and its promoter. Specific lack of expression in neoplastic JB6 cells may reflect altered gene methylation. J. Biol. Chem. 270, 19312-19319 (1995).
39. McElligott, A.M., Baker, A.H. & McGlynn, H. Matrix metalloproteinase and tissue inhibitor of metalloproteinase regulation of the invasive potential of a metastatic renal cell line. Biochem. Soc. Trans. 25, 147S (1997).
40. Airola, K. et al. Human TIMP-3 is expressed during fetal development, hair growth cycle, and cancer progression. J. Histochem. Cytochem. 46, 437-447 (1998).
41. Byrne, J.A. et al. The tissue inhibitor of metalloproteinases-3 gene in breast carcinoma: identification of multiple polyadenylation sites and a stromal pattern of expression. Mol. Med. 1, 418-427 (1995).
42. Powe, D.G. et al. TIMP-3 mRNA expression is regionally increased in moderately and poorly differentiated colorectal adenocarcinoma. Br. J. Cancer 75, 1678-1683 (1997).
43. Zeng, Z., Sun, Y., Shu, W. & Guillem, J.G. Tissue inhibitor of metalloproteinase-3 is a basement membrane-associated protein that is significantly decreased in human colorectal cancer. Dis. Colon Rectum 44, 1290-1296 (2001).
44. Uria, J.A., Ferrando, A.A., Velasco, G., Freije, J.M. & Lopez-Otin, C. Structure and expression in breast tumors of human TIMP-3, a new member of the metalloproteinase Inhibitor family. Cancer Res. 54, 2091-2094 (1994).
45. Murphy, G. & Willenbrock, F. Tissue inhibitors of matrix metalloendopeptidases. Methods Enzymol. 248, 496-510 (1995).
46. Pavloff, N., Staskus, P.W., Kishnani, N.S. & Hawkes, S.P. A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family. J. Biol. Chem. 267, 17321-17326 (1992).
47. Nguyen, M., Shing, Y. & Folkman, J. Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane. Microvasc. Res. 47, 31-40 (1994).